Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter

The Parent’s Guide to Cord Blood Foundation®’s monthly newsletter reports on research and development of medical treatments using blood and tissues from human umbilical cords in language that is accessible to parents of children receiving or considering such treatments. The June 14 issue of the newsletter features a graphical presentation of stem cell biotechnology company

June 15, 2022

Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of Its AlphaSTEM Test™ Technology as a Standard for Counting Therapeutic Adult Tissue Stem Cells

On May 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex received unanimous approval of its proposal for an interlaboratory evaluation of the company’s AlphaSTEM Test™ technology for counting therapeutic adult tissue stem cells. Highlighting the importance of the approval, a day earlier, the Standards Coordinating Body

May 21, 2019

Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of AlphaSTEM Test™ Technology Towards Establishing A Standard for Counting Therapeutic Stem Cells

Today, May 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex will present a proposal for an interlaboratory evaluation of the company’s AlphaSTEM Test™. Approval of this ASTM evaluation will be an important step in Asymmetrex’s plan to establish the AlphaSTEM Test™ as a stem cell industry

May 16, 2019

Understand Stem Cell Tools and How They Are Used

What is cryopreservation? Preserving by freezing, usually at extremely low temperatures (e.g., ≤ 130^oC). What is cryopreservation of cells? Freezing cells in a manner in which they remain viable after thawing. What is a blood spinning machine used for? To separate the cellular components of unclotted blood (red blood cells and white blood cells) from

October 10, 2018

Greater Numbers of Therapeutic Adult Tissue Stem Cells at Reduced Cost

For many years, progress in stem cell medicine has been held back because of a lack of effective and efficient methods for the manufacture of therapeutic adult tissue stem cells. Massachusetts stem cell biotechnology company Asymmetrex announces this week that it now offers a new contract service that can help suppliers of therapeutic adult tissue

August 29, 2017

AlphaSTEM Test: Established to Be a Leading Interest for Regenerative Medicine

Boston’s stem cell medicine biotechnology start-up Asymmetrex is beginning 2017 with exciting news for its recently launched contract service for counting adult tissue stem cells. The company’s webinar, produced with the international regenerative medicine social media network RegMedNet to describe Asymmetrex’s new counting technology and its applications, was 4th among the 10 most popular content

January 10, 2017

Asymmetrex Offers Contract Service For Counting Adult Tissue Stem Cells

During the fall regenerative medicine and pharmaceutical conference seasons, Boston biotechnology company Asymmetrex, LLC will announce its new contract service for counting adult tissue stem cells. In three different conference venues, the company will relate how its new AlphaSTEM Test service can provide, for the first time, stem cell dose data for stem cell treatments

August 23, 2016

Webinar: Technology for Counting Adult Tissue Stem Cells

Webinar: A first technology for counting adult tissue stem cells for applications in regenerative medicine and drug development Since the first discovery of adult tissue stem cells, it has been impossible to count them. This conundrum persists because neither morphological nor molecular properties have been defined that distinguish tissue stem cells from more abundant committed

March 23, 2016

How AlphaSTEM Technology is used to Count Adult Tissue Stem Cells

On March 22, Boston stem cell medicine technology start-up Asymmetrex will present a free, public, online webinar with the goal of discussing how it developed a stem cell technology that has been needed since the beginnings of stem cell biology. Hosted by RegMedNet, a London-based social media network for regenerative medicine professionals, the webinar will

March 17, 2016

Asymmetrex Ready to Do a Number for HSC Transplantation Therapies

Asymmetrex Ready to Do a Number for Hematopoietic Stem Cell Transplantation Therapies To prepare the field of regenerative medicine for its AlphaSTEM stem cell counting technology, Asymmetrex makes good on its earlier promise to post on the RegMedNet Industry Developments page an expose on the vexing, but silent, nature of the HSC counting problem in HSCT

February 8, 2016

Next Page »